(Q34568565)

3 August 2017

1 reference

title

ATM and breast cancer susceptibility (English)

1 reference

3 August 2017

1 reference

2

1 reference

3 August 2017

Ahmed M

1

1 reference

PubMed ID

16998505

3 August 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

3 August 2017

1 reference

3 August 2017

25

1 reference

3 August 2017

5906-5911

1 reference

3 August 2017

43

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209873

3 August 2017

0 references

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

ATM mutations in Finnish breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Models of genetic susceptibility to breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

ATM-heterozygous germline mutations contribute to breast cancer-susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

A Ser49Cys variant in the ataxia telangiectasia, mutated, gene that is more common in patients with breast carcinoma compared with population controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Dominant Negative ATM Mutations in Breast Cancer Families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Ataxia-telangiectasia, an evolving phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Clinical management of BRCA1 and BRCA2 mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

ATM heterozygosity and breast cancer: screening of 37 breast cancer patients for ATM mutations using a non-isotopic RNase cleavage-based assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Cancer risks in A-T heterozygotes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

DNA damage-induced association of ATM with its target proteins requires a protein interaction domain in the N terminus of ATM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Heterozygous ATM mutations do not contribute to early onset of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Localization of an ataxia-telangiectasia gene to chromosome 11q22-23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Functional consequences of ATM sequence variants for chromosomal radiosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

The FATC domains of PIKK proteins are functionally equivalent and participate in the Tip60-dependent activation of DNA-PKcs and ATM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

DNA damage-induced activation of ATM and ATM-dependent signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Screening breast cancer patients for Norwegian ATM mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Functional consequences of sequence alterations in the ATM gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Frequency of the ATM IVS10-6T-->G variant in Australian multiple-case breast cancer families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Constitutional alterations of the ATM gene in early onset sporadic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Radiosensitivity of ataxia telangiectasia and Nijmegen breakage syndrome homozygotes and heterozygotes as determined by three-color FISH chromosome painting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

The CHEK2 gene and inherited breast cancer susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Breast and other cancers in 1445 blood relatives of 75 Nordic patients with ataxia telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

The ATRs, ATMs, and TORs are giant HEAT repeat proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

The ATM-mediated DNA-damage response: taking shape.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Elevated frequency of ATM gene missense mutations in breast cancer relative to ethnically matched controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

ATM missense mutations are frequent in patients with breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Residual ataxia telangiectasia mutated protein function in cells from ataxia telangiectasia patients, with 5762ins137 and 7271T-->G mutations, showing a less severe phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Breast and other cancers in families with ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Common ataxia telangiectasia mutated haplotypes and risk of breast cancer: a nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Molecular pathology of ataxia telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Increased frequency of ATM mutations in breast carcinoma patients with early onset disease and positive family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Two ATM variants and breast cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Cancer risks and mortality in heterozygous ATM mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

FAT: a novel domain in PIK-related kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

Cancer risk in heterozygotes for ataxia-telangiectasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

7 January 2021

Identification of germline missense mutations and rare allelic variants in theATM gene in early-onset breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

7 January 2021

Breast cancer in female carriers of ATM gene alterations: outcome of adjuvant radiotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

7 January 2021

Prevalence of germline truncating mutations in ATM in women with a second breast cancer after radiation therapy for a contralateral tumor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

7 January 2021

Mutagen sensitivity of human lymphoblastoid cells with a BRCA1 mutation in comparison to ataxia telangiectasia heterozygote cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

7 January 2021

Incidence of cancer in 161 families affected by ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209873

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209873

1 reference

PubMed ID

16998505

Dimensions Publication ID

3 August 2017

0 references

1 reference

PubMed ID

16998505